These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7559953)

  • 41. Enzyme-linked immunosorbent assay with Trypanosoma cruzi excreted-secreted antigens (TESA-ELISA) for serodiagnosis of acute and chronic Chagas' disease.
    Umezawa ES; Nascimento MS; Stolf AM
    Diagn Microbiol Infect Dis; 2001 Mar; 39(3):169-76. PubMed ID: 11337184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].
    Moretti E; Cervetta L; Basso B; Castro I; Santamarina N
    Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Levels of anti-B13 antibodies over time in a cohort of chronic infected by Trypanosoma cruzi. Its relationship with specific treatment and clinical status.
    Olivera V; Bizai ML; Arias E; Suasnabar S; Bottasso O; Marcipar I; Fabbro D
    Acta Trop; 2021 Jun; 218():105908. PubMed ID: 33789152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymerase chain reaction reveals Trypanosoma cruzi infection suspected by serology in cutaneous and mucocutaneous leishmaniasis patients.
    Chiaramonte MG; Frank FM; Furer GM; Taranto NJ; Margni RA; Malchiodi EL
    Acta Trop; 1999 Apr; 72(3):295-308. PubMed ID: 10232785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serodiagnosis of Chagas' disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigens.
    Peralta JM; Teixeira MG; Shreffler WG; Pereira JB; Burns JM; Sleath PR; Reed SG
    J Clin Microbiol; 1994 Apr; 32(4):971-4. PubMed ID: 8027352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Innovations in diagnosis and post-therapeutic monitoring of Chagas disease: Simultaneous flow cytometric detection of IgG1 antibodies anti-live amastigote, anti-live trypomastigote, and anti-fixed epimastigote forms of Trypanosoma cruzi.
    Alessio GD; Côrtes DF; Machado de Assis GF; Júnior PA; Ferro EA; Antonelli LR; Teixeira-Carvalho A; Martins-Filho OA; de Lana M
    J Immunol Methods; 2014 Nov; 413():32-44. PubMed ID: 25064148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression in Escherichia coli of a dominant immunogen of Trypanosoma cruzi recognized by human chagasic sera.
    Cotrim PC; Paranhos GS; Mortara RA; Wanderley J; Rassi A; Camargo ME; da Silveira JF
    J Clin Microbiol; 1990 Mar; 28(3):519-24. PubMed ID: 1691209
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of an enzyme-linked immunosorbent assay that utilizes the Tc13Tul antigen of Trypanosoma cruzi to monitor patients after treatment with benznidazole.
    Santamaría AL; De Rissio AM; Riarte A; Garavaglia PA; Bruballa AC; Rodríguez MA; Irazu LE; Ruiz AM; García GA
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):197-205. PubMed ID: 23537784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Demonstration of Trypanosoma cruzi antigen in serum from patients with Chagas' disease.
    Araujo FG; Chiari E; Dias JC
    Lancet; 1981 Jan; 1(8214):246-9. PubMed ID: 6109902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic performance of tests based on Trypanosoma cruzi excreted-secreted antigens in an endemic area for Chagas' disease in Bolivia.
    Zarate-Blades CR; Bladés N; Nascimento MS; da Silveira JF; Umezawa ES
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):229-32. PubMed ID: 17020793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum antibodies to Trypanosoma cruzi antigens in Atacameños patients from highland of northern Chile.
    González J; Neira I; Gutiérrez B; Anacona D; Manque P; Silva X; Marín S; Sagua H; Vergara U
    Acta Trop; 1996 Feb; 60(4):225-36. PubMed ID: 8659322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice.
    Martinez-Campos V; Martinez-Vega P; Ramirez-Sierra MJ; Rosado-Vallado M; Seid CA; Hudspeth EM; Wei J; Liu Z; Kwityn C; Hammond M; Ortega-López J; Zhan B; Hotez PJ; Bottazzi ME; Dumonteil E
    Vaccine; 2015 Aug; 33(36):4505-12. PubMed ID: 26192358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of recombinant trypomastigote surface antigens of Trypanosoma cruzi in screening sera from a population in rural northeastern Brazil endemic for Chagas' disease.
    Cetron MS; Hoff R; Kahn S; Eisen H; Van Voorhis WC
    Acta Trop; 1992 Feb; 50(3):259-66. PubMed ID: 1348602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High molecular weight proteins of Trypanosoma cruzi reduce cross-reaction with Leishmania spp. in serological diagnosis tests.
    Cervantes-Landín AY; Martínez I; Schabib M; Espinoza B
    Biomed Res Int; 2014; 2014():365403. PubMed ID: 25136581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exoantigens from trypanosoma cruzi contain cruzipain.
    Gruppi A; Cerbán FM; Vottero-Cima E
    Acta Trop; 1997 Feb; 63(2-3):141-9. PubMed ID: 9088427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens.
    Umezawa ES; Bastos SF; Coura JR; Levin MJ; Gonzalez A; Rangel-Aldao R; Zingales B; Luquetti AO; da Silveira JF
    Transfusion; 2003 Jan; 43(1):91-7. PubMed ID: 12519436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the ELISA-F29 test as an early marker of therapeutic efficacy in adults with chronic Chagas disease.
    Fabbro D; Velazquez E; Bizai ML; Denner S; Olivera V; Arias E; Pravia C; Ruiz AM
    Rev Inst Med Trop Sao Paulo; 2013; 55(3):. PubMed ID: 23740013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Shift of excretory-secretory immunogens of Trypanosoma cruzi during human Chagas' disease.
    Jazín EE; Luquetti AO; Rassi A; Frasch AC
    Infect Immun; 1991 Jun; 59(6):2189-91. PubMed ID: 1903775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular mimicry between Trypanosoma cruzi and host nervous tissues.
    Avila JL
    Acta Cient Venez; 1992; 43(6):330-40. PubMed ID: 1343745
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease.
    Michailowsky V; Luhrs K; Rocha MO; Fouts D; Gazzinelli RT; Manning JE
    Infect Immun; 2003 Jun; 71(6):3165-71. PubMed ID: 12761095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.